Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 18

1.

The effectiveness and cost effectiveness of telephone counselling and the nicotine patch in a state tobacco quitline.

Hollis JF, McAfee TA, Fellows JL, Zbikowski SM, Stark M, Riedlinger K.

Tob Control. 2007 Dec;16 Suppl 1:i53-9.

2.

'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis.

Wang D, Connock M, Barton P, Fry-Smith A, Aveyard P, Moore D.

Health Technol Assess. 2008 Feb;12(2):iii-iv, ix-xi, 1-135. Review.

3.

Telephone counselling for smoking cessation.

Stead LF, Hartmann-Boyce J, Perera R, Lancaster T.

Cochrane Database Syst Rev. 2013 Aug 12;(8):CD002850. doi: 10.1002/14651858.CD002850.pub3. Review.

PMID:
23934971
4.

Telephone counselling for smoking cessation.

Stead LF, Perera R, Lancaster T.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD002850. Review. Update in: Cochrane Database Syst Rev. 2013;8:CD002850.

PMID:
16855992
5.

Cost effectiveness analysis of smoking cessation interventions.

Shearer J, Shanahan M.

Aust N Z J Public Health. 2006 Oct;30(5):428-34. Review.

PMID:
17073223
6.

Relapse prevention in UK Stop Smoking Services: current practice, systematic reviews of effectiveness and cost-effectiveness analysis.

Coleman T, Agboola S, Leonardi-Bee J, Taylor M, McEwen A, McNeill A.

Health Technol Assess. 2010 Oct;14(49):1-152, iii-iv. doi: 10.3310/hta14490. Review.

7.

Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.

Keating GM, Lyseng-Williamson KA.

Pharmacoeconomics. 2010;28(3):231-54. doi: 10.2165/11204380-000000000-00000. Review.

PMID:
20108995
8.
9.

A meta-analysis of the efficacy of over-the-counter nicotine replacement.

Hughes JR, Shiffman S, Callas P, Zhang J.

Tob Control. 2003 Mar;12(1):21-7. Review.

10.

Cost-effectiveness of pharmacological interventions for smoking cessation: a literature review and a decision analytic analysis.

Song F, Raftery J, Aveyard P, Hyde C, Barton P, Woolacott N.

Med Decis Making. 2002 Sep-Oct;22(5 Suppl):S26-37. Review.

PMID:
12369228
11.

A systematic review of interventions for smokers who contact quitlines.

Stead LF, Perera R, Lancaster T.

Tob Control. 2007 Dec;16 Suppl 1:i3-8. Review.

12.

Effectiveness of over-the-counter nicotine replacement therapy: a qualitative review of nonrandomized trials.

Hughes JR, Peters EN, Naud S.

Nicotine Tob Res. 2011 Jul;13(7):512-22. doi: 10.1093/ntr/ntr055. Epub 2011 Apr 6. Review. Erratum in: Nicotine Tob Res. 2012 Dec;14(12):1499.

14.

Tobacco quitlines: looking back and looking ahead.

Anderson CM, Zhu SH.

Tob Control. 2007 Dec;16 Suppl 1:i81-6. Review.

15.

A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report.

Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel, Liaisons, and Staff.

Am J Prev Med. 2008 Aug;35(2):158-76. doi: 10.1016/j.amepre.2008.04.009. Review.

16.

Quitlines in North America: evidence base and applications.

Ossip-Klein DJ, McIntosh S.

Am J Med Sci. 2003 Oct;326(4):201-5. Review.

PMID:
14557735
17.

Minimal dataset for quitlines: a best practice.

Campbell HS, Ossip-Klein D, Bailey L, Saul J; North American Quitline Consortium.

Tob Control. 2007 Dec;16 Suppl 1:i16-20. Review.

18.

Quitline Activity in Rajasthan, India.

Gupta R, Verma V, Mathur P.

Asian Pac J Cancer Prev. 2016;17 Suppl 2:19-24. Review.

Items per page

Supplemental Content

Write to the Help Desk